Great questions! Since these medications interact differently with each person's health profile, a dermatologist is really the best person to assess what's right for your specific situation — especially with other health factors in play.
Here's a quick breakdown of what's generally known about these vitiligo treatments:
- Show Full Answer
Great questions! Since these medications interact differently with each person's health profile, a dermatologist is really the best person to assess what's right for your specific situation — especially with other health factors in play.
Here's a quick breakdown of what's generally known about these vitiligo treatments:
- Ruxolitinib (Opzelura) — A topical JAK inhibitor applied directly to the skin. Because it's topical, it carries a lower risk of whole-body side effects compared to oral medications. It's FDA-approved for nonsegmental vitiligo in people 12 and older.
- Tacrolimus — Another topical option, meaning systemic effects are also more limited.
- Upadacitinib (Rinvoq) — This is an *oral* JAK inhibitor, which means it works throughout the whole body and may carry more considerations around immune function and other health conditions. Immune-related concerns are definitely something doctors weigh carefully, particularly with oral JAK inhibitors. Topical options like Opzelura tend to have a more favorable safety profile in that regard.
The honest answer is — only your doctor can determine what's safe given your full health picture. It's worth having a direct conversation with your dermatologist about all your health factors so they can tailor the best treatment plan for you.
May 9